Absence of CCR5-Δ32 mutation in healthy and HIV-1-infected aborigines in eastern Taiwan

Tzu Chi Medical Journal

Volumn 14, Issue 6, 2002, Pages 353-357

  Cherng, Jaw Ming ^a,b,c,d   Wang, Ji Hung ^a,b,c,d   Hsu, Wen Lin ^a   Yang, Kuo Liang ^a   Lin, Hsiao Yi ^d   Wang, Chrong Reen ^d   Lin, Chi Mo ^a,b,c,d   Wang, Lih Shinn ^a,b,c,d  

^a BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^b B Compassion Relief Tzu Chi Found   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

^d NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

CCR5; Deletion mutation; Ethnic variation; Human immunodeficiency virus type 1

Indexed keywords

CHEMOKINE RECEPTOR CCR5; GENOMIC DNA; NUCLEOTIDE;

ABORIGINE; ADULT; AGAR GEL ELECTROPHORESIS; ARTICLE; CAUCASIAN; CHINESE; ETHNIC DIFFERENCE; FEMALE; GENE AMPLIFICATION; GENE DELETION; GENE MUTATION; GENE STRUCTURE; GENOTYPE; HOMOZYGOSITY; HONG KONG; HOST CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; TAIWAN;

EID: 0036892254     PISSN: 10163190     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Levy JA: Pathogenesis of human immunodeficiency virus infection. Microbiol Rev 1993; 57:183-289.
2. Dean M, Carrington M, Winkler C, et al: Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study. Science 1996; 273: 1856-1862.
3. Liu R, Paxton WA, Choe S, et al: Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 1996; 86:367-377.
4. Cammack N: Human immunodeficiency virus type 1 entry and chemokine receptors: A new therapeutic target. Antivir Chem Chemother 1999; 10:53-62.
5. Feng Y, Broder CC, Kennedy PE, Berger EA: HIV-1 entry cofactor: Functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 1996; 272:872-877.
6. Samson M, Libert F, Doranz BJ, et al: Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 1996; 382:722-725.
7. Olbrich H, Proudfoot AE, Oppermann M: Chemokine-induced phosphorylation of CC chemokine receptor 5 (CCR5). J Leukoc Biol 1999; 65:281-285.
8. Zhu T, Mo H, Wang N, et al: Genotypic and phenotypic characterization of HIV-1 patients with primary infection. Science 1993; 261:1179-1181.
9. Connor RI, Ho DD: Human immunodeficiency virus type 1 variants with increased replicative capacity develop during the asymptomatic stage before disease progression. J Virol 1994; 68:4400-4408.
10. Samson M, Soularue P, Vassart G, Parmentier M: The genes encoding the human CC-chemokine receptors CC-CKR1 to CC-CKR5 (CMKBR1-CMKBR5) are clustered in the p21.3-p24 region of chromosome 3. Genomics 1996; 36:522-526.
11. Carrington M, Dean M, Martin MP, O'Brien SJ: Genetics of HIV-1 infection: Chemokine receptor CCR5 polymorphism and its consequences. Hum Mol Genet 1999; 8:1939-1945.
12. Benkirane M, Jin DY, Chun RF, Koup RA, Jeang KT: Mechanism of transdominant inhibition of CCR5-mediated HIV-1 infection by ccr5delta32. J Biol Chem 1997; 272:30603-30606.
13. Huang Y, Paxton WA, Wolinsky SM, et al: The role of a mutant CCR5 allele in HIV-1 transmission and disease progression. Nat Med 1996; 2:1240-1243.
14. Paxton WA, Martin SR, Tse D, et al: Relative resistance to HIV-1 infection of CD4 lymphocytes from persons who remain uninfected despite multiple high-risk sexual exposure. Nat Med 1996; 2:412-417.
15. Rappaport J, Cho YY, Hendel H, Schwartz EJ, Schachter F, Zagury JF: 32 bp CCR-5 gene deletion and resistance to fast progression in HIV-1 infected heterozygotes. Lancet 1997; 349:922-923.
16. Dean M, Jacobson LP, McFarlane G, et al: Reduced risk of AIDS lymphoma in individuals heterozygous for the CCR5-delta32 mutation. Cancer Res 1999; 59:3561-3564.
17. Li C, Yan YP, Shieh B, Lee CM, Lin RY, Chen YM: Frequency of the CCR5 delta 32 mutant allele in HIV-1-positive patients, female sex workers, and a normal population in Taiwan. J Formos Med Assoc 1997; 96: 979-984.
18. Umetsu K, Yuasa I, Suzuki T, et al: Polymorphisms of complement component I and C1R subcomponent of C1 in nine aboriginal Taiwanese populations. Hum Biol 1994; 66:339-348.
19. Martinson JJ, Chapman NH, Rees DC, Liu YT, Clegg JB: Global distribution of the CCR5 gene 32-basepair deletion. Nat Genet 1997; 16:100-103.